Diseases /

Multiple Endocrine Neoplasia Type 1

Back to Diseases List
Associated Genetic Biomarkers

Overview

NCI Definition: Multiple endocrine neoplasia caused by inactivation of the tumor suppressor gene MEN-1. Patients may develop hyperparathyroidism and parathyroid gland adenomas, pituitary gland adenomas, pancreatic islet cell neoplasms, and carcinoid tumors. [1]

Clinical Trials

View Clinical Trials for Multiple Endocrine Neoplasia Type 1

Significant Genes in Multiple Endocrine Neoplasia Type 1

MEN1 +

Disease Details

Synonyms
Multiple Endocrine Adenomatosis, Type I, Wermer Syndrome, multiple endocrine neoplasia type 1 syndrome, Multiple Endocrine Neoplasia Type I, MEN 1, MEA Type 1, MEA Type I, Wermer's Syndrome, MEN Type 1, Multiple Endocrine Adenomatosis Type I, Multiple Endocrine Adenomatosis Type 1, MEN Type I, MEN1 syndrome, Multiple Endocrine Neoplasia, Type I
Parent(s)
Autosomal Dominant Disorder

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.